Recent advances in brain tumor-targeted nano-drug delivery systems

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Expert Opinion on Drug Delivery

• Publication date

  2012-05-18

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1517/17425247.2012.682726PMID 22607535
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polymersomes.

  2019cited by this paper
• Modern methods for delivery of drugs across the blood-brain barrier.

  2012cited by this paper
• Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases.

  2012cited by this paper
• PEG/RGD-modified magnetic polymeric liposomes for controlled drug release and tumor cell targeting.

  2012cited by this paper
• The use of myristic acid as a ligand of polyethylenimine/DNA nanoparticles for targeted gene therapy of glioblastoma

  2011cited by this paper
• The molecular pathobiology of metastasis to the brain: a review.

  2011cited by this paper
• PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.

  2011cited by this paper
• Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides.

  2011cited by this paper
• Tumor delivery of macromolecular drugs based on the EPR effect.

  2011cited by this paper
• Cyclic RGD-poly(ethylene glycol)-polyethyleneimine is more suitable for glioblastoma targeting gene transfer in vivo

  2011cited by this paper
• Enhanced pulmonary absorption of a macromolecule through coupling to a sequence-specific phage display-derived peptide.

  2011cited by this paper
• Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor.

  2011cited by this paper
• Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer.

  2011cited by this paper
• Cancer theranostics: the rise of targeted magnetic nanoparticles.

  2011cited by this paper
• Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.

  2011cited by this paper
• Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects.

  2011cited by this paper
• Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals.

  2011cited by this paper
• Brain delivery and cellular internalization mechanisms for transferrin conjugated biodegradable polymersomes.

  2011cited by this paper
• Molecular heterogeneity in glioblastoma: therapeutic opportunities and challenges.

  2011cited by this paper
• PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors.

  2011cited by this paper
• The role of the organ microenvironment in brain metastasis.

  2011cited by this paper
• Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles.

  2011cited by this paper
• Cancer Nanotheranostics: Improving Imaging and Therapy by Targeted Delivery Across Biological Barriers

  2011cited by this paper
• High-affinity peptide against MT1-MMP for in vivo tumor imaging.

  2011cited by this paper
• Effects of photoacoustic imaging and photothermal ablation therapy mediated by targeted hollow gold nanospheres in an orthotopic mouse xenograft model of glioma.

  2011cited by this paper
• RGD‐Modified PEG‐PAMAM‐DOX Conjugate: In Vitro and In Vivo Targeting to Both Tumor Neovascular Endothelial Cells and Tumor Cells

  2011influential reference
• Cationized Albumin Conjugated Solid Lipid Nanoparticles as Vectors for Brain Delivery of an Anti-Cancer Drug

  2011influential reference
• Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity.

  2011cited by this paper
• Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin.

  2011cited by this paper
• Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.

  2011cited by this paper
• Anti glioma effect of doxorubicin loaded liposomes modified with angiopep-2

  2011cited by this paper
• Micelle-based brain-targeted drug delivery enabled by a nicotine acetylcholine receptor ligand.

  2011cited by this paper
• RGD-modified PEG-PAMAM-DOX conjugates: in vitro and in vivo studies for glioma.

  2011cited by this paper
• TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes.

  2011cited by this paper
• Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery?

  2011cited by this paper
• Poly(ethylene glycol)-block-poly(d,l-lactide acid) micelles anchored with angiopep-2 for brain-targeting delivery

  2011cited by this paper
• Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.

  2011cited by this paper
• Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting.

  2011cited by this paper
• A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein.

  2011cited by this paper
• Brain tumor stem cells: The cancer stem cell hypothesis writ large

  2010cited by this paper
• Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin.

  2010cited by this paper
• D-peptide inhibitors of the p53–MDM2 interaction for targeted molecular therapy of malignant neoplasms

  2010cited by this paper
• Phage library-screening: a powerful approach for generation of targeting-agents specific for normal pancreatic islet-cells and islet-cell carcinoma in vivo.

  2010cited by this paper
• Surface Expressed Nucleolin Is Constantly Induced in Tumor Cells to Mediate Calcium-Dependent Ligand Internalization

  2010influential reference
• Structure and function of the blood-brain barrier.

  2010cited by this paper
• Experimental approaches for the treatment of malignant gliomas.

  2010cited by this paper
• Loop 2 of Ophiophagus hannah toxin b binds with neuronal nicotinic acetylcholine receptors and enhances intracranial drug delivery.

  2010cited by this paper
• Possibilities of new therapeutic strategies in brain tumors.

  2010cited by this paper
• Distinguishing glioma recurrence from treatment effect after radiochemotherapy and immunotherapy.

  2010cited by this paper
• Targeted imaging and therapy of brain cancer using theranostic nanoparticles.

  2010cited by this paper
• Tat-BMPs-PAMAM Conjugates Enhance Therapeutic Effect of Small Interference RNA on U251 Glioma Cells In Vitro and In Vivo

  2010cited by this paper
• Phage display: concept, innovations, applications and future.

  2010cited by this paper
• Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches.

  2010cited by this paper
• Enhanced efficacy of functionalized epirubicin liposomes in treating brain glioma-bearing rats.

  2010cited by this paper
• Lactoferrin-conjugated biodegradable polymersome holding doxorubicin and tetrandrine for chemotherapy of glioma rats.

  2010cited by this paper
• Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.

  2010cited by this paper
• A Comparative Study of Transfection Efficiency between Liposomes, Immunoliposomes and Brain-specific Immunoliposomes

  2010cited by this paper
• Cyclic RGD peptide-labeled upconversion nanophosphors for tumor cell-targeted imaging.

  2009cited by this paper
• What are the experiences of the child with a brain tumour and their parents?

  2009cited by this paper
• Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.

  2009cited by this paper
• Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.

  2009cited by this paper
• Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model.

  2009cited by this paper
• Delivery of sodium borocaptate to glioma cells using immunoliposome conjugated with anti-EGFR antibodies by ZZ-His.

  2009cited by this paper
• Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB).

  2009cited by this paper
• Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel.

  2009cited by this paper
• Brain tumor stem cells: view from cell proliferation.

  2009cited by this paper
• Convection-enhanced delivery of nanocarriers for the treatment of brain tumors.

  2009cited by this paper
• Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells

  2008influential reference
• The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain.

  2008cited by this paper
• Identification and Design of Peptides as a New Drug Delivery System for the Brain

  2008cited by this paper
• [Expression and activity of membrane surface tissue factor in peripheral blood cells of patients with cerebral infarction].

  2008cited by this paper
• Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability.

  2008cited by this paper
• Involvement of the low‐density lipoprotein receptor‐related protein in the transcytosis of the brain delivery vector Angiopep‐2

  2008cited by this paper
• Therapeutic potential of chlorotoxin-like neurotoxin from the Chinese scorpion for human gliomas.

  2007cited by this paper
• New ways in RGD-peptide mediated drug targeting to angiogenic endothelium : On the nature of drugs, linkers, and carriers.

  2007cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci.

  2007cited by this paper
• Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle.

  2007cited by this paper
• The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer.

  2006cited by this paper
• Delivery of hydrophobised 5-fluorouracil derivative to brain tissue through intravenous route using surface modified nanogels

  2006cited by this paper
• Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours.

  2006cited by this paper
• Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration.

  2006cited by this paper
• Glioblastoma multiforme and the epidermal growth factor receptor.

  2005cited by this paper
• Crossing the blood-brain barrier: A potential application of myristoylated polyarginine for in vivo neuroimaging

  2005cited by this paper
• Permeability of the blood-brain barrier to HIV-1 Tat.

  2005cited by this paper
• Glucose-receptor MR imaging of tumors: study in mice with PEGylated paramagnetic niosomes.

  2004cited by this paper
• Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.

  2004cited by this paper
• Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing mice

  2004cited by this paper
• Primary brain tumours in adults.

  2003cited by this paper
• Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.

  2003cited by this paper
• Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels

  2003cited by this paper
• Primary brain tumours in adults.

  2003cited by this paper
• Regulation of blood-brain tumor barrier permeability by calcium-activated potassium channels.

  2002cited by this paper
• Co-localization of GLUT1 and GLUT4 in the blood-brain barrier of the rat ventromedial hypothalamus.

  2001cited by this paper
• Crossing the blood-brain barrier: are we getting it right?

  2001cited by this paper
• Quasi-periodic substructure in the microvessel endothelial glycocalyx: a possible explanation for molecular filtering?

  2001cited by this paper
• Mechanisms of glucose transport at the blood-brain barrier: an in vitro study.

  2001cited by this paper
• Histochemical characterization of primary capillary endothelial cells from porcine brains using monoclonal antibodies and fluorescein isothiocyanate-labelled lectins: implications for drug delivery.

  2001cited by this paper
• The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery.

  2000cited by this paper
• Suppression of facilitative glucose transporter 1 mRNA can suppress tumor growth.

  2000cited by this paper

• Nanoengineered immune check point inhibitors delivery for targeted brain cancer treatment: Current status and future perspectives.

  2025cites this paper
• Trojan Horse Delivery Strategies of Natural Medicine Monomers: Challenges and Limitations in Improving Brain Targeting

  2025cites this paper
• Melatonin alleviates oxidative stress induced damage in human iPSCs harboring mtDNA 3243A>G mutation via MAPK pathway

  2025cites this paper
• Exosomal delivery of rapamycin modulates blood-brain barrier penetration and VEGF axis in glioblastoma.

  2025cites this paper
• Harnessing nanotechnology for improved drug delivery across the blood-brain barrier and enhanced neural repair.

  2025cites this paper
• Nanoparticle-based delivery systems for targeted therapy in brain tumors: Progress, challenges and perspectives (Review)

  2025cites this paper
• Nanosystems at Nexus: Navigating Nose-to-Brain Delivery for Glioblastoma Treatment.

  2025cites this paper
• Progress in the Application of Nanomaterials in Tumor Treatment

  2025cites this paper
• Size-Dependent Glioblastoma Targeting by Polymeric Nanoruler with Prolonged Blood Circulation.

  2024cites this paper
• Cancer signaling, cell/gene therapy, diagnosis and role of nanobiomaterials

  2024cites this paper
• Tumor-Homing Peptides as Crucial Component of Magnetic-Based Delivery Systems: Recent Developments and Pharmacoeconomical Perspective

  2024cites this paper
• Overcoming brain barriers through surface-functionalized liposomes for glioblastoma therapy; current status, challenges and future perspective.

  2024cites this paper
• Cell Membrane Fragment-Wrapped Parenteral Nanoemulsions: A New Drug Delivery Tool to Target Gliomas

  2024cites this paper
• Improving the Biopharmaceutical Properties of Cannabinoids in Glioblastoma Multiforme Therapy With Nanotechnology: A Drug Delivery Perspective

  2024cites this paper
• A Novel ANG-BSA/BCNU/ICG MNPs Integrated for Targeting Therapy of Glioblastoma

  2024cites this paper
• Harnessing Magnetic Resonance-Guided Focused Ultrasound for Precise Blood-Brain Barrier Disruption: Advancements in Targeted Therapeutics for Neurological Disorders

  2024cites this paper
• T7 Peptide-modified macrophage membrane-coated nanoplatform for enhanced glioma treatment.

  2024cites this paper
• Polyamidoamine Dendrimers: Brain-Targeted Drug Delivery Systems in Glioma Therapy

  2024cites this paper
• Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials

  2023cites this paper
• Protein Corona on Brain Targeted Nanocarriers: Challenges and Prospects.

  2023cites this paper
• Lipid-Based Nanocarriers in the Treatment of Glioblastoma Multiforme (GBM): Challenges and Opportunities

  2023cites this paper
• Gamma-ray-responsive drug delivery systems for radiation protection

  2023cites this paper
• Transferrin receptor 1 targeted nanomedicine for brain tumor therapy.

  2023cites this paper
• Biopolymer Nanoparticles for Nose-to-Brain Drug Delivery: A New Promising Approach for the Treatment of Neurological Diseases

  2022cites this paper
• Specific anti‐glioma targeted‐delivery strategy of engineered small extracellular vesicles dual‐functionalised by Angiopep‐2 and TAT peptides

  2022cites this paper
• Big Data Analysis of Manufacturing and Preclinical Studies of Nanodrug-Targeted Delivery Systems: A Literature Review

  2022cites this paper
• Drug Nanocrystals for Active Tumor-Targeted Drug Delivery

  2022cites this paper
• All-stage targeted therapy for the brain metastasis from triple-negative breast cancer

  2022cites this paper
• Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-)clinical studies with an emphasis on vesicles.

  2022cites this paper
• Controllable blood–brain barrier (BBB) regulation based on gigahertz acoustic streaming

  2022cites this paper
• PDA-Based Drug Delivery Nanosystems: A Potential Approach for Glioma Treatment

  2022cites this paper
• Targeted drug delivery systems to control neuroinflammation in central nervous system disorders

  2021cites this paper
• Nanomedicines for Brain Drug Delivery

  2021influential citation
• Integrin αvβ3-targeted liposomal drug delivery system for enhanced lung cancer therapy.

  2021cites this paper
• Drug delivery and targeting to brain tumors: considerations for crossing the blood-brain barrier

  2021cites this paper
• Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics.

  2021cites this paper
• A novel ANG-BSA/BCNU/ICG MNPs integrated for targeting therapy of glioblastoma

  2021cites this paper
• Preparation of cationized albumin nanoparticles loaded indirubin by high pressure hemogenizer

  2021cites this paper
• NOSE-TO-BRAIN DELIVERY, A ROUTE OF CHOICE FOR TARGETING BRAIN TUMORS

  2021cites this paper
• Highlights in targeted nanoparticles as a delivery strategy for glioma treatment.

  2021cites this paper
• Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches

  2021influential citation
• An update of advanced nanoplatforms for Glioblastoma Multiforme Management

  2021cites this paper
• Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches

  2021cites this paper
• Carbon Dots: An Innovative Tool for Drug Delivery in Brain Tumors

  2021cites this paper
• Chemical Enhancement Effect of Icotinib-Au Complex Studied by Combined Density Functional Theory and Surface-Enhanced Raman Scattering.

  2021cites this paper
• Sequential Targeting in Crosslinking Nanotheranostics for Tackling the Multibarriers of Brain Tumors

  2020cites this paper
• Liposomes as Brain Targeted Delivery Systems

  2020cites this paper
• The Blood-Brain Barrier Cell-Targeted Gene Delivery System to Enhance Nerve Growth Factor Protein Secretion in the Brain.

  2020cites this paper
• Application prospect of peptide-modified nano targeting drug delivery system combined with PD-1/PD-L1 based immune checkpoint blockade in glioblastoma.

  2020cites this paper
• Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles

  2020cites this paper
• Protein-Based Drug Delivery in Brain Tumor Therapy.

  2020cites this paper
• Bioinspired Biomaterials: Advances in Tissue Engineering and Regenerative Medicine

  2020cites this paper
• Nanoparticle-based co-delivery of siRNA and paclitaxel for dual-targeting of glioblastoma.

  2020cites this paper
• The choice of anti-tumor strategies based on micromolecules or drug loading function of biomaterials.

  2020cites this paper
• Overcoming the Blood–Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours

  2020cites this paper
• Gold Nanoparticles in Glioma Theranostics.

  2020cites this paper
• Nanomedicines In Diagnosis And Treatment Of Cancer: An Update.

  2020cites this paper
• Docetaxel-loaded ultrasmall nanostructured lipid carriers for cancer therapy: in vitro and in vivo evaluation

  2020cites this paper
• Dendrimer-Based Drug Delivery Systems for Brain Targeting

  2019cites this paper
• Menthol-modified casein nanoparticles loading 10-hydroxycamptothecin for glioma targeting therapy

  2019cites this paper
• Photoacoustic Therapy for Precise Eradication of Glioblastoma with a Tumor Site Blood–Brain Barrier Permeability Upregulating Nanoparticle

  2019cites this paper
• Carrier-mediated transportation through BBB

  2019cites this paper
• Methotrexate-Loaded Solid Lipid Nanoparticles: Protein Functionalization to Improve Brain Biodistribution

  2019cites this paper
• 1 Nasal Drug Delivery of Anticancer Drugs for the 2 Treatment of Glioblastoma : Preclinical and Clinical 3 Trials 4

  2019influential citation
• Cellular and molecular mechanisms of glioblastoma malignancy: Implications in resistance and therapeutic strategies.

  2019cites this paper
• Overcoming the Physiopathologic Barriers: Nanoprobes-Mediated Intracranial Glioma Imaging

  2019cites this paper
• Therapeutic Use of Inorganic Nanomaterials in Malignant Diseases

  2019cites this paper
• Nano-engineering Nanoparticles for Clinical Use in the Central Nervous System: Clinically Applicable Nanoparticles and Their Potential Uses in the Diagnosis and Treatment of CNS Aliments

  2019cites this paper
• The Strategies of Nanomaterials for Therapy

  2019cites this paper
• Nanomedicine in Brain Diseases: Principles and Application

  2019influential citation
• Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials

  2019influential citation
• Synthesis of a biocompatible nanoporous carbon and its conjugation with florescent dye for cellular imaging and targeted drug delivery to cancer cells

  2018cites this paper
• Advances in Glioblastoma Multiforme Treatment: New Models for Nanoparticle Therapy

  2018cites this paper
• A novel peptide ligand RAP12 of LRP1 for glioma targeted drug delivery

  2018cites this paper
• Crossing the blood‐brain barrier with nanoparticles

  2018cites this paper
• A review of potential applications of MR-guided focused ultrasound for targeting brain tumor therapy.

  2018cites this paper
• Effect of Retro-Inverso Isomer of Bradykinin on Size-Dependent Penetration of Blood-Brain Tumor Barrier.

  2018cites this paper
• pH‐sensitive folic acid and dNP2 peptide dual‐modified liposome for enhanced targeted chemotherapy of glioma

  2018cites this paper
• Effect of borneol as a penetration enhancer on brain targeting of nanoliposomes: facilitate direct delivery to neurons.

  2018cites this paper
• Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy

  2018cites this paper
• Isoliquiritigenin (ISL) and its formulations: potential antitumor agents.

  2018cites this paper
• Myristic Acid-Modified DA7R Peptide for Whole-Process Glioma-Targeted Drug Delivery.

  2018cites this paper
• Peptides as a therapeutic avenue for nanocarrier-aided targeting of glioma

  2017cites this paper
• Phytochemical based nanomedicines against cancer: current status and future prospects

  2017cites this paper
• Complex effects of tumor microenvironment on the tumor disposition of carrier-mediated agents.

  2017cites this paper
• Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB.

  2017cites this paper
• MicroRNA in Glioblastoma: An Overview

  2017cites this paper
• The Expression of Connexins and SOX2 Reflects the Plasticity of Glioma Stem-Like Cells

  2017cites this paper
• Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (l-γ-glutamylglutamine)-paclitaxel nanoconjugates.

  2017cites this paper
• L-Carnitine-conjugated nanoparticles to promote permeation across blood–brain barrier and to target glioma cells for drug delivery via the novel organic cation/carnitine transporter OCTN2

  2017cites this paper
• Foe or friend? Janus-faces of the neurovascular unit in the formation of brain metastases

  2017cites this paper
• Stapled RGD Peptide Enables Glioma-Targeted Drug Delivery by Overcoming Multiple Barriers.

  2017cites this paper
• On-Demand Drug Release from Dual-Targeting Small Nanoparticles Triggered by High-Intensity Focused Ultrasound Enhanced Glioblastoma-Targeting Therapy.

  2017cites this paper
• Realizing the therapeutic potential of rare earth elements in designing nanoparticles to target and treat glioblastoma.

  2017cites this paper
• Design of Y‐shaped targeting material for liposome‐based multifunctional glioblastoma‐targeted drug delivery

  2017cites this paper
• Solid lipid nanoparticles by coacervation loaded with a methotrexate prodrug: preliminary study for glioma treatment.

  2017cites this paper
• Managing CNS Tumors: The Nanomedicine Approach Managing CNS Tumors: The Nanomedicine Approach

  2017cites this paper
• Gold nanoconjugates reinforce the potency of conjugated cisplatin and doxorubicin.

  2017cites this paper
• Pep-1 peptide-functionalized liposome to enhance the anticancer efficacy of cilengitide in glioma treatment.

  2017cites this paper
• Time-sequenced drug delivery approaches towards effective chemotherapeutic treatment of glioma

  2017cites this paper